I've been buying UVICF pretty heavily as of recently. UVICF makes contact lenses. They made $0.11/share in their fiscal Q1'10 quarter (ending in September) and $0.42/share for the TTM. They pay a hefty dividend of $0.09/share/quarter for a yield of 8.8%. They last traded at $4.10 and have been undervalued IMO because of the overhang of 48% of their shares which were held by an entity in liquidation. They are going to buy back those share for $3.15/share pending stockholder approval which IMO is a nobrainer to approve. That buyback is going to significantly increase diluted EPS going forward to something like $0.75/share/year. IMO the stock has a good chance to double in the next six months.
News 
Market Data 
Discover 
